Intra-arterial versus intravenous cisplatinum (in addition to systemic adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. Results of a randomized study

Journal of Chemotherapy

Volumn 8, Issue 1, 1996, Pages 70-81

  Bacci, G ^a   Ruggieri, P ^b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b Laboratorio de Ricerca Oncologica   (Italy)

Author keywords

Adriamicyn; Chemotherapy; Cisplatinum; Ifosfamide; Intra arterial cisplatinum; Intravenuos cisplatinum; Local recurrence; Metastasis; Methotrexate; Osteosarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSTEOSARCOMA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; METHOTREXATE; OSTEOSARCOMA;

EID: 0030038842     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.1.70     Document Type: Article

References (17)

1. Rosen G, Caparros B, Huvos AG et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-1230.
2. Winkler K, Beron G, Schellong G et al. Kooperative-Osteosarkome-Studie COSS-77. Ergebnisse nach uber 4 Jahren. Klin Padiatric 1982: 194: 251-256.
3. Winkler K, Beron G, Kotz R et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a cooperative German/Austrian study. J Clin Oncol 1984; 2: 617-624.
4. Rosen G. Preoperative chemotherapy (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten years experience. Orthopaedics 1985; 8: 659-664.
5. Bacci G, Picci P, Ferrari S, et al. Primary chemotheraoy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high dose of methotrexate followed by cisplatinum and doxorubicin. Cancer 1993; 72: 3227-3238.
6. Bacci G, Picci P, Ruggieri P et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Rizzoli experience in 127 patients treated preoperatively with methotrexate i.v. (high vs moderate dose) and cisplatinum i.a. Cancer 1990; 65: 2539-2553.
7. Eilber F, Giuliano A, Eckardt J et al. Adjuvant chemotherapy for osteosarcoma: a randomized prospectic trial. J Clin Oncol 1987; 5: 21-28.
8. Bielack S, Delling G, Salzer-Kuntschik M et al. Influence of intraarterial turniquet infusion vs intravenous infusion of cisplatinum in osteosarcoma on histological response rate. Proc ASCO 1989; 8: 296.
9. Rosen G. The current management of malignant bone tumors. Med J Australia 1988; 148: 373-377.
10. Benjamin RS, Chawla SP, Carrasco CM, et al. Arterial infusion in the treatment of osteosarcoma. In : Ryan JR and Baker O, Recent Concepts in Sarcoma Treatment. Dordrecht: Kluver Academic Publisher 1988: 269-274.
11. Winkler K, Beron G, Belling G et al. Neoadjuvant chemotherapy of osteosarcoma. Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-337.
12. Campanacci M, Bacci G, Bertoni F, Picci P, Minutillo A, Franceschi C. The treatment of osteosarcoma of the extremities: twenty years experience at the Istituto Ortopedico Rizzoli. Cancer 1981; 48: 1569-1581.
13. Link MP, Goorin AM, Miser AW et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremities. N Engl J Med 1986; 314: 1600-1606.
14. Jaffe N, Smith D, Jaffe MR, et al.. Intraarterial cisplatinum in the management of stage IIB osteosarcoma in pediatric patients. Clin Orthop Rel Res, 1991; 270: 15-21.
15. Bacci G, Picci P, Avella M et al. Local recurrences in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy and limb salvage. Proc ASCO 1989; 8: 318.
16. Picci P, Sangiorgi L, Rougraff BT et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 1994; 12: 2699-2706.
17. Bacci G, Picci P, Ferrari S et al. Influence of Adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies. J Chemother 1993; 5: 237-246.